Canadian analyst urges investors to avoid Monsanto because of GE labeling

Monsanto Co. is the industry giant when it comes to creating, patenting and selling genetically modified (GM) seeds and associated chemicals such as the herbicide Roundup. Most of Monsanto’s sales are in the U.S. market, where there is no legal obligation to label GM ingredients as such. And this has played to Monsanto’s advantage. The company’s stock has performed ridiculously well over the last decade. It’s up about tenfold in 10 years. That’s the kind of gain people don’t complain about.

But there is a battle raging between consumers and Monsanto. I don’t have enough space in this article to dive into the science, but suffice to say that many industry experts believe genetically modified crops negatively affect our health. This is leading to a big push for better labelling, so consumers know if they are buying genetically modified foods or not.

Read the full, original story here: Monsanto: A food stock with a bad aftertaste

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend